Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.42 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.41 |
| ▸ | RELA | Q04206 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | CYP2A6 | P11509 | 4/20 | 0.40 |
| ▸ | APP | P05067 | 2/20 | 0.40 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.40 |
| ▸ | ASIC3 | Q9UHC3 | 1/20 | 0.39 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.39 |
| ▸ | MGLL | Q99685 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 2/20 | 0.39 |
| ▸ | CA12 | O43570 | 1/20 | 0.39 |
| ▸ | CA1 | P00915 | 1/20 | 0.39 |
| ▸ | CA4 | P22748 | 1/20 | 0.39 |
| ▸ | CA5A | P35218 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28400418 | 0.88 | OPRM1 (0.40) | BCL2L1CYP2A6APPADRB2ASIC3 | |
| SCHEMBL8056756 | 0.86 | SLC6A2 (0.39) | NPC1TP53HPGDNFKB1RAB9A | |
| Hydrochloric Acid SCHEMBL8050747 | 0.85 | SLC6A2 (0.38) | NPC1RAB9ACYP2A6APPADRB2 | |
| SCHEMBL28480648 | 0.81 | BCL2L1 (0.44) | BCL2L1CYP2A6APPADRB2ASIC3 | |
| SCHEMBL1254282 | 0.80 | CYP2A6 (0.44) | BCL2L1CYP2A6APPADRB2ASIC3 | |
| SCHEMBL2742932 | 0.80 | APP (0.58) | NPC1TP53HPGDNFKB1RAB9A | |
| SCHEMBL12249572 | 0.75 | APP (0.57) | NPC1TP53HPGDNFKB1RAB9A | |
| SCHEMBL24083318 | 0.75 | APP (0.53) | NPC1TP53HPGDNFKB1RAB9A | |
| Trimethylammonium SCHEMBL11529523 | 0.72 | APP (0.62) | BCL2L1APPCA2CA1CA9 | |
| SCHEMBL11161131 | 0.72 | SLC6A2 (0.35) | CYP2A6ADRB2MGLLADORA2AADORA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2588527-B1 | HOLE TRANSPORT COMPOSITIONS AND RELATED DEVICES AND METHODS (I) | NISSAN CHEMICAL IND LTD (JP) | 2017-10-25 | — | — | EP | disclosed |
| US-20170186953-A1 | HOLE TRANSPORT COMPOSITIONS AND RELATED DEVICES AND METHODS (I) | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2017-06-29 | — | — | US | disclosed |
| US-20170186953-A1 | HOLE TRANSPORT COMPOSITIONS AND RELATED DEVICES AND METHODS (I) | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2017-06-29 | — | — | US | disclosed |
| US-9577194-B2 | Hole transport compositions and related devices and methods (I) | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2017-02-21 | — | — | US | disclosed |
| US-9577194-B2 | Hole transport compositions and related devices and methods (I) | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2017-02-21 | — | — | US | disclosed |
| US-9112157-B2 | Hole transport materials including OLED applications | SOLVAY USA, INC. (US) | 2015-08-18 | — | — | US | disclosed |
| US-9112157-B2 | Hole transport materials including OLED applications | SOLVAY USA, INC. (US) | 2015-08-18 | — | — | US | disclosed |
| US-8815639-B2 | Hole transport compositions and related devices and methods (II) | SOLVAY USA, INC. (US) | 2014-08-26 | — | — | US | disclosed |
| US-8815639-B2 | Hole transport compositions and related devices and methods (II) | SOLVAY USA, INC. (US) | 2014-08-26 | — | — | US | disclosed |
| US-8535974-B2 | Hole transport compositions and related devices and methods (II) | PLEXTRONICS, INC. (US) | 2013-09-17 | — | — | US | disclosed |
| US-8535974-B2 | Hole transport compositions and related devices and methods (II) | PLEXTRONICS, INC. (US) | 2013-09-17 | — | — | US | disclosed |
| US-20120003790-A1 | HOLE TRANSPORT COMPOSITIONS AND RELATED DEVICES AMD METHODS (II) | PLEXTRONICS, INC. | 2012-01-05 | — | — | US | disclosed |
| US-20120003790-A1 | HOLE TRANSPORT COMPOSITIONS AND RELATED DEVICES AMD METHODS (II) | PLEXTRONICS, INC. | 2012-01-05 | — | — | US | disclosed |
| US-20120001127-A1 | HOLE TRANSPORT COMPOSITIONS AND RELATED DEVICES AND METHODS (I) | PLEXTRONICS, INC. | 2012-01-05 | — | — | US | disclosed |
| US-20120001127-A1 | HOLE TRANSPORT COMPOSITIONS AND RELATED DEVICES AND METHODS (I) | PLEXTRONICS, INC. | 2012-01-05 | — | — | US | disclosed |
| WO-2012003485-A2 | HOLE TRANSPORT COMPOSITIONS AND RELATED DEVICES AND METHODS (I) | PLEXTRONICS, INC. (US) | 2012-01-05 | — | — | WO | disclosed |
| WO-2012003482-A2 | HOLE TRANSPORT COMPOSITIONS AND RELATED DEVICES AND METHODS (II) | PLEXTRONICS, INC. (US) | 2012-01-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120001127-A1 | HOLE TRANSPORT COMPOSITIONS AND RELATED DEVICES AND METHODS (I) | OCIAD2, OCIAD1, SLCO1B1 | BCL2L1 1924/4885NPC1 20/4885TP53 4548/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.